You are invited to the 2nd School of Chemoinformatics in Latin America. Held online from December 4-6, 2024 Preliminary program 👉 schoolchilatina.com The registration is open and free: 👉 schoolchilatina.com/registration/ #chemoinformatics #LatinAmerica #school #openscience

🔊 ¡El 1er Congreso de Investigación de la FacultadMedicinaUNAM se acerca! Agenda tu lugar en auditorios a partir del 21 de agosto de 9:00 a 15:00 horas. 👀 Consulta toda la info. ⬇️ di.facmed.unam.mx/cidi2024/ #UNAM #FacMed #fmposgrado #medicina #médicos #Residentes Div de Investigación

Estimados integrantes de esta comunidad, Por este medio, me permito compartir con todos ustedes el canal de YouTube del Laboratorio de Farmacología Molecular de la Facultad de Medicina, UNAM. youtube.com/@labfamol_fm?s…

Our recent work on pranlukast role in PD-L1 stabilization was published in Anti-Cancer Agents in Medicinal Chemistry. This study highlights its potential as an antineoplastic drug. eurekaselect.com/article/143856

Invitación cordial. Registro libre en us06web.zoom.us/meeting/regist… #compchem #productosnaturales #quimioinformatica

Join us at the 2nd School of #Chemoinformatics in #LatinAmerica and listen to the talks of bright stars in the chemoinformatics space. Registration is #free 👉 schoolchilatina.com/registration/ Program👉schoolchilatina.com Miguel Angel Chavez Fumagalli, PhD Ramirez Lab Luis Córdova Norberto Sánchez Cruz

As Guest Editors for JoVE, we are organizing a Method Collection titled "Computationally Driven Drug Discovery And Development". Interested in contributing? Please submit an abstract here: app.jove.com/methods-collec… #CasFutureLeaders #LatinxChem CompChemBio Bot 💻💊🧬🤖

Hi friends and colleagues!! We are editing a collection with JoVE. 📹💊 If you have an innovative #InSilico method applicable to #DrugDesign, this is your chance to publish it in video format and expand its impact! 🔗 Submit you work now: app.jove.com/methods-collec…

The world needs science, and science needs women. 👩‍🔬🧪 Yet, they remain under-represented and struggle to get recognition for their achievements. More from UNESCO 🏛️ #Education #Sciences #Culture 🇺🇳 on Tuesday’s International Day of Women & Girls in Science: on.unesco.org/WomenInScience

Sharing our latest work: “In Silico Characterization of the Interaction of AKR1B1 with the DAD domain.” AKR1B1 may compete with HDAC3 for binding to NCOR1/2. We modeled the complex and identified 6 key residues, including L289. frontiersin.org/journals/molec…

Sharing our latest work! We identified potential inhibitors of CK1ε, a key player in cancer. Using pharmacophore-based virtual screening, docking, and molecular dynamics, we found 2,4-diaminopyrimidine compounds with promising inhibitory activity. mdpi.com/1424-8247/18/5…

Daclatasvir, a symmetric drug for an anti-symmetric target biorxiv.org/content/10.110… #biorxiv_cancer

Our new preprint is out! We identify FDA-approved drugs to target the PD-1/PD-L1 axis in cancer immunotherapy. Highlight: the antiviral daclatasvir shows promising potential. Read here: biorxiv.org/content/10.110… #DrugRepurposing #Immunotherapy #CancerResearch #Daclatasvir

New papers posted on August 13, 2025: 16 in biochemistry: biorxiv.org/collection/bio… 3 in bioengineering: biorxiv.org/collection/bio… 4 in bioinformatics: biorxiv.org/collection/bio… 15 in biophysics: biorxiv.org/collection/bio… 16 in cancer biology: biorxiv.org/collection/can…